Xu Ling, Zhou Qiao-ling, Han Jie, Zhang Dan-ying, Dong Hui-juan, Cai Zai-long, Yu Chao-qin, Zhai Dong-xia
Department of Traditional Chinese Medicine, Second Military Medical University, Shanghai, China.
Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):800-6. doi: 10.3736/jcim20120711.
To compare angiopoiesis ability of eutopic and ectopic endometrial tissue isolated from women with endometriosis and endometrium isolated from women without endometriosis (control), and to explore the inhibitory effects of medicated serum of Neiyi Recipe, a compound traditional Chinese herbal medicine.
Chick chorioallantoic membrane (CAM) model of endometriosis was established by transplanting endometrium onto CAM. The CAMs were then hatched with blank serum or medicated serum of danazol or Neiyi Recipe, which were prepared in rats by orally administering. The sizes of the transplanted tissue and new vessels around the transplanted tissue were measured. Expression of vascular endothelial growth factor (VEGF) was detected by immunohistochemical method.
There was no difference in the sizes of transplanted tissue among CAM models of ectopic and eutopic endometrial tissue isolated from women with endometriosis or control (P>0.05), and more new vessels were found around the ectopic and eutopic endometrial tissue than the endometrial tissue of control (P<0.05). Compared with the controls, the size of the transplanted tissue and positive area of new vessels were significantly inhibited by Neiyi Recipe-medicated serum (P<0.01, P<0.05), and similar changes happened in the danazol groups, except for the size of transplanted tissue from ectopic endometrial tissue (P>0.05). Expression of VEGF was significantly higher in eutopic and ectopic endometrial tissue than in the control (P<0.01); the level of VEGF obviously reduced in the Neiyi Recipe and danazol groups (P<0.01), but no significant difference was detected between them.
Endometrium from women with endometriosis stimulates the formation of new vessels by increase the expression of VEGF. Neiyi Recipe-medicated serum significantly decreases the expression of VEGF in eutopic and ectopic endometrial tissues and thus restrains the formation of new vessels, reduces the blood supply and inhibits growth of ectopic endometrial tissue, which are similar to danazol, but has greater efficacy in suppressing the expression of VEGF.
比较从子宫内膜异位症患者分离出的在位及异位子宫内膜组织与从非子宫内膜异位症患者(对照组)分离出的子宫内膜的血管生成能力,并探讨中药复方内异方含药血清的抑制作用。
将子宫内膜移植到鸡胚绒毛尿囊膜(CAM)上,建立子宫内膜异位症的CAM模型。然后用空白血清、经大鼠口服给药制备的达那唑或内异方含药血清孵育CAM。测量移植组织的大小及移植组织周围新生血管的数量。采用免疫组化法检测血管内皮生长因子(VEGF)的表达。
从子宫内膜异位症患者或对照组分离出的异位及在位子宫内膜组织的CAM模型中,移植组织大小无差异(P>0.05),且异位及在位子宫内膜组织周围新生血管比对照组子宫内膜组织多(P<0.05)。与对照组相比,内异方含药血清显著抑制移植组织大小及新生血管阳性面积(P<0.01,P<0.05),达那唑组也有类似变化,但异位子宫内膜组织移植组织大小除外(P>0.05)。在位及异位子宫内膜组织中VEGF表达明显高于对照组(P<0.01);内异方组和达那唑组VEGF水平明显降低(P<0.01),但两组间无显著差异。
子宫内膜异位症患者的子宫内膜通过增加VEGF表达刺激新生血管形成。内异方含药血清显著降低在位及异位子宫内膜组织中VEGF表达,从而抑制新生血管形成,减少血液供应,抑制异位子宫内膜组织生长,与达那唑相似,但在抑制VEGF表达方面疗效更佳。